Literature DB >> 1534814

Preferential increase of IL-2R+ CD4+ T cells and CD45RB- CD4+ T cells in the central nervous system in experimental allergic encephalomyelitis.

M A Jensen1, B G Arnason, A Toscas, A Noronha.   

Abstract

We examined lymphocytes isolated from the spinal cord (SC), peripheral blood (PB) and lymph nodes (LN) draining the immunization site of Lewis rats with acute experimental allergic encephalomyelitis (EAE). Cells were analysed for T cell subset markers CD4 (mAb W3/25) and CD8 (mAb OX8), for IL-2R (mAb OX39), and for high molecular mass leukocyte common antigen (LCA, CD45RB) expression (mAb OX22). T cells expressing high (CD45RB+) or low (CD45RB-) molecular mass LCA are of different maturational stages and/or separate lineages. CD4+ T cells were more predominant in SC than in PB and LN; CD8+ T cells were scarce in SC but common in PB and LN. Activated CD4+ T cells (IL-2R+) were common in the SC and LN but infrequent in blood. CD4+ T cells that were CD45RB+ were scarce in the SC. In contrast, the majority of CD4+ T cells in the PB and LN were CD45RB+. The preferential accumulation of IL-2R+ CD4+ T cells and of CD45RB- CD4+ T cells in the central nervous system (CNS) indicates that a selective mechanism directs cell egress into CNS lesions in EAE.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1534814     DOI: 10.1016/0165-5728(92)90018-g

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

1.  CCR4 contributes to the pathogenesis of experimental autoimmune encephalomyelitis by regulating inflammatory macrophage function.

Authors:  Eileen A Forde; Rukiye-Nazan E Dogan; William J Karpus
Journal:  J Neuroimmunol       Date:  2011-05-14       Impact factor: 3.478

2.  Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice.

Authors:  Max Winerdal; Malin Elisabeth Winerdal; Johan Kinn; Vijay Urmaliya; Ola Winqvist; Ulrika Adén
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

Review 3.  Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination.

Authors:  Victor Longoria; Hannah Parcel; Bameelia Toma; Annu Minhas; Rana Zeine
Journal:  Biomedicines       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.